rdf:type |
|
lifeskim:mentions |
umls-concept:C0020501,
umls-concept:C0021270,
umls-concept:C0022646,
umls-concept:C0022671,
umls-concept:C0023884,
umls-concept:C0030705,
umls-concept:C0038952,
umls-concept:C0439165,
umls-concept:C0450127,
umls-concept:C0521115,
umls-concept:C0596545
|
pubmed:issue |
10
|
pubmed:dateCreated |
2003-12-5
|
pubmed:abstractText |
Combined liver-kidney transplantation is the definitive treatment for end-stage renal disease caused by primary hyperoxaluria type I (PH1). The infantile form is characterized by renal failure early in life, advanced systemic oxalosis, and a formidable mortality rate. Although others have reported on overall results of transplantation for PH1 covering a wide age spectrum, none has specifically addressed the high-risk infantile form of the disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0041-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1458-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14657686-Body Constitution,
pubmed-meshheading:14657686-Body Mass Index,
pubmed-meshheading:14657686-Creatinine,
pubmed-meshheading:14657686-Follow-Up Studies,
pubmed-meshheading:14657686-Graft Rejection,
pubmed-meshheading:14657686-Graft Survival,
pubmed-meshheading:14657686-Growth,
pubmed-meshheading:14657686-Humans,
pubmed-meshheading:14657686-Hyperoxaluria, Primary,
pubmed-meshheading:14657686-Infant,
pubmed-meshheading:14657686-Infection,
pubmed-meshheading:14657686-Kidney Transplantation,
pubmed-meshheading:14657686-Liver Transplantation,
pubmed-meshheading:14657686-Oxalates,
pubmed-meshheading:14657686-Postoperative Complications,
pubmed-meshheading:14657686-Reproducibility of Results,
pubmed-meshheading:14657686-Retrospective Studies,
pubmed-meshheading:14657686-Survival Rate,
pubmed-meshheading:14657686-Time Factors,
pubmed-meshheading:14657686-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience.
|
pubmed:affiliation |
Stanford University School of Medicine, Palo Alto, CA 94304, USA. mmillan@stanford.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|